Floating Point, a venture capital firm based in both New York City and Boston, has successfully closed its second fund, securing $70 million in investments.

Founded in 2021 by Eddie Segel and John Loser, former investors at Bridgewater and founding team members of Oscar Health, Floating Point specializes in investing in complex sectors often overlooked by traditional investors.

Investment Focus and Portfolio:

With a focus on building a distinctive venture portfolio at the intersection of technology and legacy industries, Floating Point now manages over $150 million in assets.

The firm’s portfolio includes diverse investments in companies such as Altana, Commons Clinic, Sun Day, Floodbase, and Wheeler Bio, among others, aiming to uncover hidden opportunities in various sectors.

Team and Venture Partners:

Floating Point’s team comprises seasoned professionals and venture partners with extensive experience in technology and healthcare sectors.

Notable venture partners include Evan Moore, co-founder of DoorDash; Serkan Piantino, co-founder of Facebook AI Research; Vin Mitta, M.D., Medical Officer at CMS; Jesse Horowitz, CPO at Oscar Health; and Bruce Gottlieb, COO of Flatiron Health.

Expansion and Institutional Backing:

The successful closure of its second fund reflects Floating Point’s growing presence in the venture capital landscape.

Backed by institutional, private equity, and family office investors, including 53 Stations, the venture arm of The Pritzker Organization, Floating Point is poised to continue its mission of identifying and investing in innovative companies across diverse sectors.

Conclusion:

As Floating Point expands its investment portfolio and strengthens its team, the firm remains committed to its vision of uncovering hidden opportunities and driving innovation in complex industries.

With a focus on technology-driven solutions and strategic partnerships, Floating Point is well-positioned for further growth and success in the evolving venture capital landscape.